Privatebancorp (NASDAQ:PVTB) certainly gave investors and traders a few things to mull over after the close on Wednesday. First, the bank holding company released third
Nothing stirs an early morning buzz in traders like a company reporting solid earnings. While investors sipped their morning coffee, Fastenal (NASDAQ: FAST) added a
Traders usually take notice when an executive buys a boatload of its company’s stock. According to an article today from Forbes, the Chief Investment Officer
In Iceland, they eat a delicacy known as rotted shark, where the fish is hung out to dry for several months in preparation for human
Investors in Questcor (NASDAQ: QCOR) received a double dose of positive news this morning that helped bring a little color to what has been a
What impact will the distribution agreement that calls for Express Scripts (NASDAQ: ESRX) to sell the anti-obesity drug Qsymia, manufactured by VIVUS (NASDAQ: VVUS), have
What comes out of the oven when a downtrodden stock mixes with a pinch of good news? According to a Seeking Alpha article on Friday,
Nothing slaps equities buyers in the face like a cold, wet towel more than the word “investigation”. Over the weekend, Faruqi and Faruqi announced it was
Is NVIDIA (NASDAQ: NVDA) making serious inroads versus Intel (NASDAQ: INTC) in the area of GPU computing? According to some sources, the company may have landed
Executives of MRV Communications (OTC: MVRC) must wonder what the company must do to get traders tuned back to the company’s stock. After MRV issued
One of the world’s leading research and advisory companies recently estimated the total income generated by social media sites like Facebook (NASDAQ: FB), LinkedIn (NASDAQ:
A research report put out by Goldman yesterday failed to keep the ground from shaking underneath the feet of traders in Terra Tech (OTC: TRTC).
OncoSec Medical (OTC: ONCS) announced that it would be presenting at the 3rd Annual Cancer Immunotherapy Conference on October 4, 2012, at the New York Academy of
Patients enduring the rigors of chemotherapy know all too well about nauseas side effects of the treatment. In extreme cases, the nausea and vomiting is
Like Dorothy talking to the scarecrow in The Wizard of Oz, traders must be confused on what direction to take when it comes to shares
Privatebancorp (NASDAQ:PVTB) certainly gave investors and traders a few things to mull over after the close on Wednesday. First, the bank holding company released third
Nothing stirs an early morning buzz in traders like a company reporting solid earnings. While investors sipped their morning coffee, Fastenal (NASDAQ: FAST) added a
Traders usually take notice when an executive buys a boatload of its company’s stock. According to an article today from Forbes, the Chief Investment Officer
In Iceland, they eat a delicacy known as rotted shark, where the fish is hung out to dry for several months in preparation for human
Investors in Questcor (NASDAQ: QCOR) received a double dose of positive news this morning that helped bring a little color to what has been a
What impact will the distribution agreement that calls for Express Scripts (NASDAQ: ESRX) to sell the anti-obesity drug Qsymia, manufactured by VIVUS (NASDAQ: VVUS), have
What comes out of the oven when a downtrodden stock mixes with a pinch of good news? According to a Seeking Alpha article on Friday,
Nothing slaps equities buyers in the face like a cold, wet towel more than the word “investigation”. Over the weekend, Faruqi and Faruqi announced it was
Is NVIDIA (NASDAQ: NVDA) making serious inroads versus Intel (NASDAQ: INTC) in the area of GPU computing? According to some sources, the company may have landed
Executives of MRV Communications (OTC: MVRC) must wonder what the company must do to get traders tuned back to the company’s stock. After MRV issued
One of the world’s leading research and advisory companies recently estimated the total income generated by social media sites like Facebook (NASDAQ: FB), LinkedIn (NASDAQ:
A research report put out by Goldman yesterday failed to keep the ground from shaking underneath the feet of traders in Terra Tech (OTC: TRTC).
OncoSec Medical (OTC: ONCS) announced that it would be presenting at the 3rd Annual Cancer Immunotherapy Conference on October 4, 2012, at the New York Academy of
Patients enduring the rigors of chemotherapy know all too well about nauseas side effects of the treatment. In extreme cases, the nausea and vomiting is
Like Dorothy talking to the scarecrow in The Wizard of Oz, traders must be confused on what direction to take when it comes to shares
